Literature DB >> 15386663

Comparing costing results in across country economic evaluations: the use of technology specific purchasing power parities.

Sarah Wordsworth1, Anne Ludbrook.   

Abstract

The number of economic evaluations conducted on a multinational basis is increasing. Therefore, techniques are required to compare the results of such studies in a meaningful manner. This paper explores different approaches to comparing across country cost data applied to a European study of dialysis therapy for end-stage renal disease. A price and volume index is created at the level of the individual health care technology and compared to an exchange rate conversion and published purchasing power parities (PPPs). Both exchange rate and PPP conversions when published rates are used fail to accurately reflect the true resource use of the applied health care example. These differences can be related to specific issues of input mix and price variation. Alternatively, the use of technology specific PPPs provided a more robust approach for international comparisons and also have the potential for use in multi-centre economic evaluations within the same country. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2005        PMID: 15386663     DOI: 10.1002/hec.913

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  6 in total

1.  The analysis of multinational cost-effectiveness data for reimbursement decisions: a critical appraisal of recent methodological developments.

Authors:  Andrea Manca; Mark J Sculpher; Ron Goeree
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

Review 2.  End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF).

Authors:  Avi Dor; Mark V Pauly; Margaret A Eichleay; Philip J Held
Journal:  Int J Health Care Finance Econ       Date:  2007-09

3.  Bayesian modelling of healthcare resource use in multinational randomized clinical trials.

Authors:  Aline Gauthier; Andrea Manca; Susan Anton
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

4.  An economic assessment model for in-center, conventional home, and more frequent home hemodialysis.

Authors:  Paul Komenda; Meghan B Gavaghan; Susan S Garfield; Amy W Poret; Manish M Sood
Journal:  Kidney Int       Date:  2011-10-12       Impact factor: 10.612

5.  Three years evaluation of peritoneal dialysis and hemodialysis absorption costing: perspective of the service provider compared to funds transfers from the public and private healthcare systems.

Authors:  Alyne Schreider; Celso Souza de Moraes Júnior; Natália Maria da Silva Fernandes
Journal:  J Bras Nefrol       Date:  2022 Apr-Jun

6.  The burden of stroke in the Netherlands: estimating quality of life and costs for 1 year poststroke.

Authors:  M van Eeden; C van Heugten; G A P G van Mastrigt; M van Mierlo; J M A Visser-Meily; S M A A Evers
Journal:  BMJ Open       Date:  2015-11-27       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.